Insider · CIK 0001652437
Sudhindra Kankanwadi
officercfo
Files at SNPS (SYNOPSYS INC). First filing Sep 23, 2025, latest Oct 6, 2026.
Track record
Not enough history
Fewer than three past buys with six months of prices.
Median 6-month excess
-
after past buys, n = 0
Hit rate
-
past buys that beat the index over 6 months
Open-market trades
0 / 2
$0 bought, $14M sold
Where the trades landed
Last year at the company this insider has traded most, with each buy and sell on the bar it happened.
SNPS: SYNOPSYS INC
SNPSOct 9, 2026 · close 509.99
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value. Click a marked bar to open the signal.Charts by TradingView Lightweight Charts™
Signals
This insider’s open-market buys and sells, scored.
| Score | Company | Value | Holdings | Price context | Filed |
|---|---|---|---|---|---|
| 50Moderate | SYNOPSYS INC | $6.0M 12,170 shares | -47% | +33% from low-9% from high | |
| 53Moderate | SYNOPSYS INC | $7.8M 15,873 shares | -60% | +30% from low-23% from high |
Transactions
Every row this insider has filed, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Oct 5, 2026 | SNPS SYNOPSYS INC | MOption exercise Common Stock | +3,000 | $135.88 | $408k | 25,717 | 6 d ago |
| Oct 5, 2026 | SNPS SYNOPSYS INC | SOpen-market sale Common Stock | -3,000 | $484.78 | $1.5M | 22,717 | 6 d ago |
| Oct 6, 2026 | SNPS SYNOPSYS INC | MOption exercise Common Stock | +9,170 | $135.88 | $1.2M | 31,887 | 6 d ago |
| Oct 6, 2026 | SNPS SYNOPSYS INC | SOpen-market sale Common Stock | -9,170 | $500.00 | $4.6M | 22,717 | 6 d ago |
| Oct 5, 2026 | SNPS SYNOPSYS INC | MOption exercise Non-Qualified Stock Option (right to buy)derivative | -3,000 | $0.00 | $0 | 9,170 | 6 d ago |
| Oct 6, 2026 | SNPS SYNOPSYS INC | MOption exercise Non-Qualified Stock Option (right to buy)derivative | -9,170 | $0.00 | $0 | 0 | 6 d ago |
| Aug 31, 2026 | SNPS SYNOPSYS INC | JOther Common Stock | +27 | $360.96 | $9,746 | 22,717 | 40 d ago |
| Dec 16, 2025 | SNPS SYNOPSYS INC | AGrant or award Restricted Stock Unitsderivative | +4,317 | $0.00 | $0 | 4,317 | Dec 18, 2025 |
| Dec 8, 2025 | SNPS SYNOPSYS INC | MOption exercise Common Stock | +740 | $0.00 | $0 | 21,260 | Dec 9, 2025 |
| Dec 8, 2025 | SNPS SYNOPSYS INC | FTax withholding Common Stock | -367 | $465.75 | $171k | 20,893 | Dec 9, 2025 |
| Dec 8, 2025 | SNPS SYNOPSYS INC | MOption exercise Common Stock | +562 | $0.00 | $0 | 21,455 | Dec 9, 2025 |
| Dec 8, 2025 | SNPS SYNOPSYS INC | FTax withholding Common Stock | -279 | $465.75 | $130k | 21,176 | Dec 9, 2025 |
| Dec 8, 2025 | SNPS SYNOPSYS INC | MOption exercise Common Stock | +1,012 | $0.00 | $0 | 22,188 | Dec 9, 2025 |
| Dec 8, 2025 | SNPS SYNOPSYS INC | FTax withholding Common Stock | -502 | $465.75 | $234k | 21,686 | Dec 9, 2025 |
| Dec 8, 2025 | SNPS SYNOPSYS INC | MOption exercise Restricted Stock Unitsderivative | -740 | $0.00 | $0 | 0 | Dec 9, 2025 |
| Dec 8, 2025 | SNPS SYNOPSYS INC | MOption exercise Restricted Stock Unitsderivative | -562 | $0.00 | $0 | 4,158 | Dec 9, 2025 |
| Dec 8, 2025 | SNPS SYNOPSYS INC | MOption exercise Restricted Stock Unitsderivative | -1,012 | $0.00 | $0 | 3,146 | Dec 9, 2025 |
| Sep 19, 2025 | SNPS SYNOPSYS INC | MOption exercise Common Stock | +6,000 | $89.76 | $539k | 26,520 | Sep 23, 2025 |
| Sep 19, 2025 | SNPS SYNOPSYS INC | SOpen-market sale Common Stock | -6,000 | $482.00 | $2.9M | 20,520 | Sep 23, 2025 |
| Sep 22, 2025 | SNPS SYNOPSYS INC | MOption exercise Common Stock | +9,873 | $89.76 | $886k | 30,393 | Sep 23, 2025 |
| Sep 22, 2025 | SNPS SYNOPSYS INC | SOpen-market sale Common Stock | -9,873 | $500.90 | $4.9M | 20,520 | Sep 23, 2025 |
| Sep 19, 2025 | SNPS SYNOPSYS INC | MOption exercise Non-Qualified Stock Option (right to buy)derivative | -6,000 | $0.00 | $0 | 9,873 | Sep 23, 2025 |
| Sep 22, 2025 | SNPS SYNOPSYS INC | MOption exercise Non-Qualified Stock Option (right to buy)derivative | -9,873 | $0.00 | $0 | 0 | Sep 23, 2025 |
| Aug 29, 2025 | SNPS SYNOPSYS INC | JOther Common Stock | +26 | $376.77 | $9,796 | 20,520 | Sep 3, 2025 |
| Mar 15, 2025 | SNPS SYNOPSYS INC | MOption exercise Common Stock | +794 | $0.00 | $0 | 20,780 | Mar 18, 2025 |
| Mar 15, 2025 | SNPS SYNOPSYS INC | FTax withholding Common Stock | -286 | $446.23 | $128k | 20,494 | Mar 18, 2025 |
| Mar 15, 2025 | SNPS SYNOPSYS INC | MOption exercise Restricted Stock Unitsderivative | -794 | $0.00 | $0 | 1,586 | Mar 18, 2025 |
| Feb 28, 2025 | SNPS SYNOPSYS INC | JOther Common Stock | +25 | $388.69 | $9,717 | 19,986 | Mar 4, 2025 |
| Dec 18, 2024 | SNPS SYNOPSYS INC | AGrant or award Non-Qualified Stock Option (right to buy)derivative | +2,959 | $0.00 | $0 | 2,959 | Dec 20, 2024 |
| Dec 18, 2024 | SNPS SYNOPSYS INC | AGrant or award Restricted Stock Unitsderivative | +3,034 | $0.00 | $0 | 4,720 | Dec 20, 2024 |
| Dec 6, 2024 | SNPS SYNOPSYS INC | MOption exercise Common Stock | +881 | $0.00 | $0 | 19,657 | Dec 10, 2024 |
| Dec 6, 2024 | SNPS SYNOPSYS INC | FTax withholding Common Stock | -352 | $517.28 | $182k | 19,305 | Dec 10, 2024 |
| Dec 6, 2024 | SNPS SYNOPSYS INC | MOption exercise Common Stock | +741 | $0.00 | $0 | 20,046 | Dec 10, 2024 |
| Dec 6, 2024 | SNPS SYNOPSYS INC | FTax withholding Common Stock | -368 | $517.28 | $190k | 19,678 | Dec 10, 2024 |
| Dec 6, 2024 | SNPS SYNOPSYS INC | MOption exercise Common Stock | +563 | $0.00 | $0 | 20,241 | Dec 10, 2024 |
| Dec 6, 2024 | SNPS SYNOPSYS INC | FTax withholding Common Stock | -280 | $517.28 | $145k | 19,961 | Dec 10, 2024 |
| Dec 6, 2024 | SNPS SYNOPSYS INC | MOption exercise Restricted Stock Unitsderivative | -881 | $0.00 | $0 | 0 | Dec 10, 2024 |
| Dec 6, 2024 | SNPS SYNOPSYS INC | MOption exercise Restricted Stock Unitsderivative | -741 | $0.00 | $0 | 740 | Dec 10, 2024 |
| Dec 6, 2024 | SNPS SYNOPSYS INC | MOption exercise Restricted Stock Unitsderivative | -563 | $0.00 | $0 | 1,686 | Dec 10, 2024 |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.